Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

A blood pressure drug, diltiazem, may also help treat influenza.

Tofacitinib helped a woman regrow hair with no major side effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Tofacitinib may help regrow hair in alopecia areata patients.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JAK inhibitors are effective treatments for alopecia areata.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Urokinase, a type of protein, helps skin cells multiply faster, especially in newborn mice.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Platelet-rich plasma treatment shows early improvement in femur head avascular necrosis.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

The FDA approved a new Pfizer drug for hair loss in teens.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib significantly improved skin and hair conditions without side effects.